Global Viral Vector Manufacturing Market Set for Exponential Growth, Forecasted to Reach .55 Billion by 2028
Global Viral Vector Manufacturing Market Set for Exponential Growth, Forecasted to Reach .55 Billion by 2028

Viral Vector Manufacturing Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033

The Business Research Company’s Viral Vector Manufacturing Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033

You Can Now Pre Order Your Report To Get A Swift Deliver With All Your Needs”

— The Business research company

LONDON, GREATER LONDON, UK, July 4, 2024 / — The global viral vector manufacturing market is poised for substantial growth, projected to expand from $5.82 billion in 2023 to $7 billion in 2024, marking a robust compound annual growth rate (CAGR) of 20.4%. This growth in recent years can be attributed to the burgeoning pipeline of gene therapies, successful clinical outcomes, increased investments in biopharmaceuticals, and rising prevalence of genetic disorders.

Expanding Applications in Oncology and Vaccine Development Driving Market Growth
The viral vector manufacturing market is expected to continue its exponential growth trajectory, reaching $14.55 billion by 2028 with a CAGR of 20.0%. Key drivers in this forecast period include the widening applications in oncology treatments, global collaborations in gene therapy research, adoption of viral vectors in vaccine development, ongoing clinical trials, and commercialization efforts.

Explore comprehensive insights into the global viral vector manufacturing market with a detailed sample report:

Technological Innovations and Regulatory Compliance Shape Market Trends
Innovations in vector production technologies, emergence of next-generation vectors, stringent regulatory standards, and increased standardization efforts are prominent trends driving the market forward. Collaborations and partnerships among biopharmaceutical firms and the expansion of manufacturing facilities globally further bolster market dynamics.

Viral Vector Manufacturing Market Segments
• Type: Adenoviral Vectors, Adeno-Associated Viral Vectors, Lentiviral Vectors, Retroviral Vectors, Other Types
• Disease: Cancer, Genetic Disorders, Infectious Diseases, Other Diseases
• Workflow: Upstream Processing, Downstream Processing
• Application: Gene And Cell Therapy Development, Vaccine Development, Biopharmaceutical And Pharmaceutical Discovery, Biomedical Research
• End-User: Research Organizations, Biotech And Pharmaceutical Companies, Others End Users

Regional Insights: Asia-Pacific Spearheading Growth
North America led the viral vector manufacturing market in 2023, driven by advanced biotech infrastructure and significant research investments. However, Asia-Pacific is anticipated to emerge as the fastest-growing region during the forecast period, supported by expanding healthcare infrastructure and increasing adoption of advanced medical technologies.

Key Players Driving Market Innovations
Major companies actively shaping the viral vector manufacturing landscape include Sanofi S.A., Thermo Fisher Scientific Inc., Merck Group, FUJIFILM Holdings Corporation, Lonza Group, Catalent Inc., Sartorius AG, Charles River Laboratories International Inc., AGC Biologics, and more. These players are focusing on developing advanced viral vector platforms tailored for efficient production and processing, catering to the growing demand for gene therapies and vaccine development.

Make your report purchase here and explore the whole industry’s data as well

Viral Vector Manufacturing Global Market Report 2024 from TBRC covers the following information:
• Market size data for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.

The Viral Vector Manufacturing Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on viral vector manufacturing market size, viral vector manufacturing market drivers and trends, viral vector manufacturing market major players, competitors’ revenues, market positioning, and market growth across geographies. The viral vector manufacturing market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:

Viral Vectors And Plasmid DNA Global Market Report 2024

Vector Control Global Market Report 2024

Bacterial And Plasmid Vectors Global Market Report 2024

About The Business Research Company
The Business Research Company has published over 27 industries, spanning over 8000+ markets and 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:

Article originally published on as Global Viral Vector Manufacturing Market Set for Exponential Growth, Forecasted to Reach $14.55 Billion by 2028